Key facts
- This page summarizes William Lewis's Form 4 filing for INSMED Inc (INSM).
- 6 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 10 Jan 2024, 16:15.
William Lewis - 08 Jan 2024 Form 4 Insider Report for INSMED Inc (INSM)
- Reporting relationship
- Chair and CEO, Director
- Issuer ticker
- INSM
- Reported as of
- 08 Jan 2024
- Net transaction value
- +$236,090
- SEC form
- 4
- Accepted by SEC
- 10 Jan 2024, 16:15:15 UTC
- Prior SEC filing
- 08 Jan 2024
- Next SEC filing
- 29 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ William Lewis, by Michael A. Smith as Attorney in Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
William Lewis filed Form 4 for INSMED Inc (INSM) on 10 Jan 2024.
Change
- Previous filing in this sequence was filed on 08 Jan 2024.
- Current net transaction value: +$236,090.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INSM
transaction
Common Stock
Options Exercise
- Transaction value
- $511,246
- Shares
- +24,951
- Change %
- +6.7%
- Price
- $20.49
- Shares after
- 398,489
- Date
- 08 Jan 2024
- Ownership
- Direct
- Footnotes
- F1
INSM
transaction
Common Stock
Sale
- Transaction value
- $726,324
- Shares
- -24,951
- Change %
- -6.3%
- Price
- $29.11
- Shares after
- 373,538
- Date
- 08 Jan 2024
- Ownership
- Direct
- Footnotes
- F1, F2
INSM
transaction
Common Stock
Options Exercise
- Transaction value
- $413,263
- Shares
- +20,169
- Change %
- +5.4%
- Price
- $20.49
- Shares after
- 393,707
- Date
- 08 Jan 2024
- Ownership
- Direct
- Footnotes
- F1
INSM
transaction
Common Stock
Sale
- Transaction value
- $602,650
- Shares
- -20,169
- Change %
- -5.1%
- Price
- $29.88
- Shares after
- 373,538
- Date
- 08 Jan 2024
- Ownership
- Direct
- Footnotes
- F1, F3
INSM
transaction
Common Stock
Sale
- Transaction value
- $283,955
- Shares
- -9,887
- Change %
- -2.6%
- Price
- $28.72
- Shares after
- 363,651
- Date
- 09 Jan 2024
- Ownership
- Direct
- Footnotes
- F4, F5
INSM
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 233,924
- Date
- 08 Jan 2024
- Ownership
- By ARTICLE 4 KATIE PROCTER DYNASTY TRUST
INSM
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 500
- Date
- 08 Jan 2024
- Ownership
- By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A11/1/2020
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INSM
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $924,509
- Shares
- +45,120
- Change %
- Price
- $20.49
- Shares after
- 0
- Date
- 08 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 45,120
- Exercise price
- $20.49
- Footnotes
- F1, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 6 footnotes
Footnote F1
This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Footnote F2
This is the weighted average sales price representing 24,951 shares sold at prices ranging from $28.71 to $29.68 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Footnote F3
This is the weighted average sales price representing 20,169 shares sold at prices ranging from $29.88 to $29.93 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Footnote F4
Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
Footnote F5
This is the weighted average sales price representing 9,887 shares sold at prices ranging from $28.62 to $28.84 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Footnote F6
Stock options granted under the Company's 2013 Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant. All options are currently exercisable and were scheduled to expire on January 10, 2024.